Role of ions in Prolactin release.
To study the role of ions in the release of Prolactin (PRL), several experiments were performed utilizing dispersed pituitary cells obtained from adult, female Sprague-Dawley rats. All tests were done after a culture period of 5 days in multiwell Petri plates at 3 x 10 5 cells per well. Culture medium was Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% horse serum, 2.5% fetal calf serum, non-essential amino-acids and antibiotics. PRL secretion was measured by specific RIA after 4 h of test incubation in various media at 37 0 in a C0 2/air incubator. Basal PRL secretion in DMEM (154±12 ng/ml) was drastically reduced in a hypoosmolar, sodium deprived medium (48±4 ng/ml) , remained low when NaCl was replaced by isoosmolar concentrations of glucose (33±2 ng/ml), and was restored by the addition of either sodium or choline 110 mH. When DA 10-llMwas added to the medium with sodium, an 83% increment of PRL secretion was observed, while the neurotransmitter was completely inactive in absence of NaCl. DA 5 x 10-6M strongly inhibited PRL release in the presence of sodium but was inactive either in the absence of the ion or when the ion channel was blocked by tetrodotoxin (TTX). Baseline and DA-stimulated PRL release were also strongly inhibited by the addition to the medium of either Co++ (a calcium channel blocker) or TTX. These results indicate that a normal ionic charge in the medium is essential for baseline PRL secretion, while both sodium and calcium ions are necessary for DA control of hormone release. tion is demonstrated. The purpose of this study was to evaluate the course and sivnificance of this association. 26 patients (6 familial) were investigated, with a followup of 4-20 yrs (x= 12.5 yrs) after onset of polyuria. Pneumoencephalography (n= 27) and/or CT scan (n= 11) were normal.
GH deficiency was present in 10/26 cases. Recovery, not related to puberty in all cases, was observed in 5 patients. TSH response to TRF (n= 17) was deficient (n= 3) or of the hypothalaMic type (n= .). Puberty was normal in 17 cases, and abnormal in 2 cases (respectively precocious and slowly progressing). GH deficiency was isolated in 5 cases or associated with ACTH +TSH (n= 1), TSH (n= 1), ACTH (n= 3) abnormalities. am Lm, injections of highly p.n-ified IGI (NanoIIllOIl R ) are described am canpared to the diurnal plasma HGI profile in eight ooIlllal children (11-14 years). Seven patients suffering fran idiopathic HGI~ficient dwarfism (age 10-19~s) received Lm. am s ,c, injection of IGI in the rorning (4IU/rn2) in randan order with an interval of one week. Lm. injections lead to a peak HGI concentration at 2 boors (mean 204,range 135-475 ng/!nl) with a return to baseline 8-10 boors after injection.Cbrresp:)J}dingly IIGI ooncentration peaked at 4 hrs (mean 38,range 15-68 ng/!nl)after s .c , injection am returned to baseline aJ:xmt 18 boors after injection.
In a subsecroent study on similar patients (n=7,age 10-19 years) IGI (2IU/rn 2) was injected svc, in the evening.1GI =ncentration peaked at 5 boors (mean 17,range 7-28 ng/!nl) am returned to baseline 14 boors after injection.'Ihe results iniicate that absorption fran an Lm. depot is far too short; to give a PlYsiological diurnal profile of IGI in plasma -even by daily aantnistration. !bweITer, daily s;c, injection will, if given in the evening, imitate ooIlllal oocturnal IGI profile.
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Dept. of Pediatrics, University of Zurich, Switzerland "A-type" isolated growth honnone deficiency (IGHD). In 1970, we presented the "A-type" of autosomal receuive IGHD characterized by early and severe growth retordation, typical face with vaulted farehead, a strong metobolic and g.-th retpanse to exagenous hGH, and a tendency to fann high GH antibodies which abolish this effect.
Recent events prompt us to report on these patients again: I) Philipps et al (abstr.Ped.Res. 1981) carried out restriction endonuclease studies In our original family A, yielding abnonnal DNA patterns of the GH genes. In other families with IGHD, they faund a nonnal pattern. 2) One of our female patients of the same family (26 years, 118 em) gave birth to a healthy girl (GA -40 weeks, 2370 g, -43 em). GH antibodies were faund not only in the mother (12 years after the end of hGH R".) but also in the newborn. Five manths later, no more antibodies were detectoble. 3) In another family we succeeded far the first time to treat a 5 year-old boy with hGH over a period of 1.5 years without the appearance of HG antibodies so far. This is in contrast to his 10 year-old brother previously treated with a different hGH preporation who developped high titre, growth-inhibiting GH antibodies. It appears that certain hGH preparations are tolerated by th_ patients who presumably suffer from a prenatol GH deficiency which may cause a lack af immunotolerance far hGH. Supported by the Swiu Notional Science Foundotion Grant No. 3.901.077
